"Surgeons told us they were looking for an enhanced design monofocal that did not sacrifice distance vision quality. TruPlus ...

“Alcon has a long legacy of advancing phaco and vitreoretinal technology for surgical ophthalmology. With UNITY VCS/CS, we are introducing more than a dozen innovations designed to transform surgical ...

Alcon (NYSE:ALC) announced today that it launched its Clareon TruPlus intraocular lens (IOL) technology in the U.S.

Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...

Give us an overview of Alcon and where it fits into India’s need for good quality eye care. Alcon has a legacy of more than ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency of ...

William Blair initiated coverage on Alcon Inc. (NYSE: ALC) on Friday with a Market Perform rating. Over the past two years, Alcon has been aggressive in driving top-line growth both internally ...

Alcon agreed to buy LENSAR for $14.00/share cash, integrating ALLY, Streamline, and the legacy laser system to expand FLACS capabilities. Regulatory clearance was a closing condition; both parties ...

Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser surgery pioneer Lensar. The deal, valued at up to $430 million, will expand Alcon ...